MedTrace Logo

Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block

NCT04480775 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2021-03-03

No results posted yet for this study

Summary

In the current Study we will compare between triamcinolone and methylprednisolone as an additive to bupivacaine drug in ultrasound guided TAP block in major open abdominal surgery .

Conditions

  • Major Abdominal Surgery

Interventions

DRUG

Triamcinolone

transversus abdominis plane block with bupivacain and triamicinolone

DRUG

Methylprednisolone

transversus abdominis plane block with bupivacaine and methylprednisolone

DRUG

bupivacaine

transversus abdominis plane block with bupivacaine alone

Sponsors & Collaborators

  • ghada fouad

    lead OTHER

Principal Investigators

  • marwa M elegemazy, master · Mansoura University

  • ghada f amer, M.D · associate professor of anesthesia

  • Eiad a ramzy, M.D · associate professor of anesthesia

  • abdelaziz a motaweaa, M.D · professor of anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2020-12-15
Completion
2020-12-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04480775 on ClinicalTrials.gov